| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
ImmunoCellular Therapeutics Ltd (PINK: IMUC)
IMUC Technical Analysis
1.5
| As on 9th Jun 2023 IMUC STOCK Price closed @ 0.35 and we RECOMMEND Sell for LONG-TERM with Stoploss of 0.43 & Buy for SHORT-TERM with Stoploss of 0.31 we also expect STOCK to react on Following IMPORTANT LEVELS. |
IMUCSTOCK Price
| Open | 0.22 | Change | Price | % |
| High | 0.35 | 1 Day | 0.15 | 75.00 |
| Low | 0.21 | 1 Week | 0.01 | 2.94 |
| Close | 0.35 | 1 Month | 0.01 | 2.94 |
| Volume | 600 | 1 Year | -0.15 | -30.00 |
| 52 Week High 0.94 | 52 Week Low 0.15 | ||||
PINK USA Most Active Stocks
| CNNA | 0.01 | 0.00% |
| AITX | 0.01 | 0.00% |
| TXGE | 1826.91 | -1.55% |
| CAVR | 0.01 | % |
| ENZC | 0.05 | 25.00% |
| OZSC | 0.01 | 0.00% |
| DPLS | 0.01 | 0.00% |
| WRFX | 0.01 | % |
| AMXVF | 1.05 | 10.53% |
| AABB | 0.03 | 0.00% |
PINK USA Top Gainers Stocks
PINK USA Top Losers Stocks
| IMUC Daily Charts |
IMUC Intraday Charts |
Whats New @ Bazaartrend |
IMUC Free Analysis |
|
|
IMUC Important Levels Intraday
| RESISTANCE | 0.62 |
| RESISTANCE | 0.53 |
| RESISTANCE | 0.48 |
| RESISTANCE | 0.43 |
| SUPPORT | 0.27 |
| SUPPORT | 0.22 |
| SUPPORT | 0.17 |
| SUPPORT | 0.08 |
IMUC Forecast May 2024
| 4th UP Forecast | 1.01 |
| 3rd UP Forecast | 0.8 |
| 2nd UP Forecast | 0.67 |
| 1st UP Forecast | 0.54 |
| 1st DOWN Forecast | 0.16 |
| 2nd DOWN Forecast | 0.03 |
| 3rd DOWN Forecast | -0.1 |
| 4th DOWN Forecast | -0.31 |
IMUC Weekly Forecast
| 4th UP Forecast | 0.83 |
| 3rd UP Forecast | 0.68 |
| 2nd UP Forecast | 0.58 |
| 1st UP Forecast | 0.49 |
| 1st DOWN Forecast | 0.21 |
| 2nd DOWN Forecast | 0.12 |
| 3rd DOWN Forecast | 0.02 |
| 4th DOWN Forecast | -0.13 |
IMUC Forecast2024
| 4th UP Forecast | 1.89 |
| 3rd UP Forecast | 1.4 |
| 2nd UP Forecast | 1.09 |
| 1st UP Forecast | 0.79 |
| 1st DOWN Forecast | -0.09 |
| 2nd DOWN Forecast | -0.39 |
| 3rd DOWN Forecast | -0.7 |
| 4th DOWN Forecast | -1.19 |
ImmunoCellular Therapeutics Ltd ( PINK USA Symbol : IMUC )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
IMUC Business Profile
ImmunoCellular Therapeutics, Ltd., a clinical-stage biotechnology company, develops immune-based therapies for the treatment of various cancers. Its products include ICT-107, a dendritic cell (DC) immunotherapy for the treatment of diagnosed glioblastoma multiforme (GBM); ICT-140, a DC-based immunotherapy targets tumor associated antigens on ovarian cancer; and ICT-121, a DC-based immunotherapy targeting CD133 markers and CSCs to treat recurrent GBM and other solid tumor cancers. The company is developing Steam-to-T-Cell immunotherapies for the treatment of cancer. It has license agreements with California Institute of Technology and The Johns Hopkins University. The company was formerly known as Optical Molecular Imaging, Inc. and changed its name to ImmunoCellular Therapeutics, Ltd. in November 2006. ImmunoCellular Therapeutics, Ltd. is based in Westlake Village, California. Address: 30721 Russell Ranch Road, Westlake Village, CA, United States, 91362
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service